Tag: Retatrutide
Browse all articles tagged with “Retatrutide”.
2 articles
Metabolic Health
Retatrutide: The Triple Agonist Setting New Records in Obesity Research
A research-focused overview of retatrutide (LY3437943), the investigational triple GIP/GLP-1/glucagon receptor agonist from Eli Lilly that achieved 23.7% body weight reduction in Phase 2 trials, the largest ever recorded in an obesity trial.
2026-03-06·15 min read
Retatrutidetriple agonistGIPGLP-1glucagonobesitymetabolic healthEli Lilly
Metabolic Health
The Complete Guide to GLP-1 Receptor Agonists: From Semaglutide to Retatrutide
An in-depth comparison of every major GLP-1 receptor agonist in research and clinical development, including semaglutide, tirzepatide, retatrutide, liraglutide, cagrilintide, survodutide, and mazdutide. Mechanism differences, efficacy data, and market positions.
2026-03-03·22 min read
GLP-1SemaglutideTirzepatideRetatrutideLiraglutideweight loss
For informational purposes only. Not medical advice. Always consult with qualified healthcare professionals.